Check Point® Software Technologies Ltd. (NASDAQ:CHKP), the worldwide leader in securing the Internet, announced its financial results for the first quarter ending March 31, 2014. Check Point Software Technologies Ltd. (NASDAQ:CHKP) shares after opening at $66.31 moved to $66.58 on last trade day and at the end of the day closed at $65.87 . Company price to sales ratio in past twelve months was calculated as 9.08 and price to cash ratio as 10.85. Check Point Software Technologies Ltd. (NASDAQ:CHKP) showed a negative weekly performance of -3.05%.
The hearing for Vringo Inc. (NASDAQ:VRNG) Germany GmbH`s lawsuit against ZTE Corporation and ZTE Deutschland GmbH regarding the German part of European patent 1,212,919, scheduled to take place on April 30, 2014 at the Mannheim Regional Court has been postponed by mutual agreement of the parties. Vringo, Inc. (NASDAQ:VRNG) shares advanced 2.13% in last trading session and ended the day on $3.84. VRNG return on equity ratio is recorded as -66.10% and its return on assets is -61.50%. Vringo, Inc. (NASDAQ:VRNG) yearly performance is 35.21%.
VMware, Inc. (NYSE:VMW) the biggest maker of software that lets computers run different operating systems, said first-quarter sales rose 14 percent as more customers renewed contracts on demand for newer products. VMware, Inc. (NYSE:VMW) shares moved down -3.03% in last trading session and was closed at $90.06 while trading in range of $88.64 – $93.40 – VMware, Inc. (NYSE:VMW) year to date (YTD) performance is 0.39%.
XOMA Corp (NASDAQ:XOMA) has reported that it will soon finalize all plans which will allow Gevokizumab Phase 3 Clinical Program in Pyoderma. XOMA Corp (NASDAQ:XOMA) has been looking at the discovery as well as the development of therapies which are based on antibodies. The company has announced that its most important drug which is the anti-bodies treatment method. XOMA Corp (NASDAQ:XOMA) weekly performance is -11.78%. On last trading day company shares ended up $3.82. XOMA Corp (NASDAQ:XOMA) distance from 50-day simple moving average (SMA50) is -36.59%. Analysts mean target price for the company is $9.25.